Department of Internal Medicine, Gastroenterology and Hepatology CCM

Projects

• Artificial Nutrition
• BPLG-005: Sustained release of human growth hormone in adult GHD
• Covered TIPPS
• cTIPS vs. optimized
• Detection of GH-doping
• Endoscopic Implantation of Enteryx® for GERD Treatment: A Randomized Sham-Controlled Multicenter Clinical Trial
• EPA bei gastrointestinalen Tumoren
• FIRM-ACT - First Internat. Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment
• Genes involved in epithelial integrity..
• GH-Doping: Development of a test method to detect GH abuse in sports
• GOLD-Study Pegvisomant in diabetic nephropathy
• Hepatische Enzephalopathie
• Hormonal Regulation of Energy Metabolism, Body Weight and Growth. GRK 1208/1
• HypoCCS: The Global Hypopituitary Control and Complications Study
• Impact of oxidative stress on muscle function
• Lanreotide and GH-antagonist in acromegalic patients
• Mediatoren der Energiehomöost
• Molecular basics of diseases in hepatology and gastroenterology
• Muscelfunction and catabolic state
• Nutzen einer poststationären Supplementa
• Ökonomische Aspekte der Mangelernährung
• Pegvisomant (MES03014/PEGA-0435-005; MES03013/PEGA-0435-003)
• sPLA2 and lipoprotein metabolism
• Wilson Disease (Eurocopper) C

If the list does not contain any entry, the request was executed without results